Fny Investment Advisers, LLC Soligenix, Inc. Transaction History

Fny Investment Advisers, LLC

  • $208 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Jan 19, 2021
SELL
$1.26 - $2.75 $112,770 - $246,125
-89,500 Closed
0 $0
Q3 2020

Oct 09, 2020
BUY
$1.7 - $2.61 $152,150 - $233,595
89,500 New
89,500 $160,000
Q2 2020

Jul 10, 2020
SELL
$1.36 - $2.26 $149,600 - $248,599
-110,000 Closed
0 $0
Q1 2020

Apr 09, 2020
BUY
$1.42 - $3.34 $156,200 - $367,400
110,000 New
110,000 $184,000

Others Institutions Holding SNGX

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About SOLIGENIX, INC.

SNGX Quotes by TradingView
  • Ticker SNGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,105,200
  • Market Cap $158M
  • Description
  • Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. It operates in two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a novel photodynamic therapy, which has c...
More about SNGX
Track This Portfolio

Track Fny Investment Advisers, LLC Portfolio

Follow Fny Investment Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fny Investment Advisers, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email